Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)
ClinicalTrials.gov study NCT02407756. IPD Sharing: Not stated. Countries: 6. Publications: 2.
A Study of the Effects of Lumacaftor/Ivacaftor (LUM/IVA) on Exercise Tolerance in Subjects With Cystic Fibrosis (CF), Homozygous for the F508del-CFTR Mutation
ClinicalTrials.gov study NCT02875366. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
ClinicalTrials.gov study NCT00838565. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
ClinicalTrials.gov study NCT06816667. IPD Sharing: YES. Countries: 1. Publications: 1.
Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD
ClinicalTrials.gov study NCT00500071. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years
ClinicalTrials.gov study NCT01299480. IPD Sharing: Not stated. Countries: 7. Publications: 3.
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
ClinicalTrials.gov study NCT04648241. IPD Sharing: YES. Countries: 1. Publications: 1.
Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3
ClinicalTrials.gov study NCT02951429. IPD Sharing: Not stated. Countries: 13. Publications: 2.
Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®
ClinicalTrials.gov study NCT03966365. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Assess the Pharmacokinetics, Safety and Tolerability of Baloxavir Marboxil in Healthy Chinese Participants
ClinicalTrials.gov study NCT03959332. IPD Sharing: NO. Countries: 1. Publications: 2.
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
ClinicalTrials.gov study NCT04002674. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
ClinicalTrials.gov study NCT00098345. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis
ClinicalTrials.gov study NCT00794664. IPD Sharing: Not stated. Countries: 6. Publications: 3.
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
ClinicalTrials.gov study NCT03160898. IPD Sharing: NO. Countries: 6. Publications: 5.
First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight Subjects
ClinicalTrials.gov study NCT04521738. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
ClinicalTrials.gov study NCT02918318. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)
ClinicalTrials.gov study NCT03615482. IPD Sharing: YES. Countries: 1. Publications: 1.
Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children
ClinicalTrials.gov study NCT01504841. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Evaluation of the Safety, Tolerability and Pharmacokinetics (PK) of GSK3732394 First-Time-in-Human (FTIH) Study
ClinicalTrials.gov study NCT03984812. IPD Sharing: YES. Countries: 1. Publications: 1.
Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)
ClinicalTrials.gov study NCT02598128. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.